Tag Archives: SEC

Biotech’s White Knight (aka Serial Cheater) Gets Prison Time, Finally

It’s been 16 years since I first reported in BioWorld Today that David Blech was charged with securities fraud. In April 1997, I reached him at his New York office a few days after his arraignment in a U.S. District…


The Small IPO: Not Dead Yet? Regulation A Debated

The biotech industry has long known it’s getting harder and harder for a small company to go public. As John Craighead, managing director of investor relations and business development for the Biotechnology Industry Organization, said during a recent conference, about…


An Optimist’s Take on Funding Options for Small Biotechs

No, that’s not a typo. I’m feeling optimistic about fundraising opportunities for small biotechs. Yes, I know we’re seeing venture firms pull back on an almost weekly basis (Prospect Ventures, Scale Venture Partners, etc.). And yes, I know the NVCA…